Is IM Cannabis Corp (IMCC) a Stock to Watch After Gaining 38.71% This Week?

IM Cannabis Corp (IMCC) stock has gained 38.71% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

IM Cannabis Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IMCC!

See Full IMCC Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With IMCC Stock Today?

IM Cannabis Corp (IMCC) stock is trading at $0.43 as of 12:22 PM on Wednesday, Mar 27, a drop of -$0.02, or -5.27% from the previous closing price of $0.46. The stock has traded between $0.41 and $0.50 so far today. Volume today is 482,140 compared to average volume of 476,294.

More About IM Cannabis Corp

IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Click Here to get the full Stock Report for IM Cannabis Corp stock.